Orthopedic implants in the United States represent a $20 billion per year industry. Seventy-five percent of the orthopedic implant industry consists of devices that are expired or soon to be expired IP (intellectual property). Typically, when a device has expired IP, manufacturers or their competitors begin to sell it as a value proposition. The reason we allow a company to have patent protection is to reward them for their innovation for a period of time. The orthopedic industry has been successful in never allowing their implants to behave in a normal market pattern. They always have been able to charge full price without letting normal market efficiencies take effect. The industry points out that they have to pay for R&D and regulatory approvals for their products and so higher prices are necessary to support these ever-increasing expenses. Pharma companies spend about 20 percent of revenues on R&D. Hip and knee companies spend 6 percent. Every drug that...
"Welcome to 'The Modern Medical Entrepreneur' – where medicine meets modernity. This channel is dedicated to the visionary healthcare professionals, especially doctors, who are passionate about blending traditional medical practices with the innovative strategies of the digital age. Whether you're looking to start your own clinic, expand an existing setup, or become a digital influencer in the medical realm, we're here to guide and inspire.